Walter Ogier co-founded the Harvard-affiliated Acetylon Pharmaceuticals (Boston MA, oncology and neurodegeneration) in 2008 and served as its President & CEO until its sale to Celgene in 2016. He subsequently served as founding President & CEO of Regenacy Pharmaceuticals Mr. Ogier currently serves as a Director of Thetis Pharmaceuticals (Branford CT), Board member Biothera Pharmaceuticals, and Nemucore Medical Innovations and Executive Chairman and Board member of Anelixis Therapeutics.
Walter has had President & CEO roles with Eligix (Medford MA, stem cells and cell therapy), Genetix/bluebird bio (Cambridge MA, stem cell gene therapy, Nasdaq: BLUE).
Mr. Ogier received a BA magna cum laude in chemistry from Williams College and an MBA from the Yale School of Management.